MeasurementsAge, sex, vital signs and medical history of all patients included in the study were recorded in a digital form. Outcome measuresOur primary aim in this study is to determine the relationship between SI and 30-day mortality. Our secondary aim is to determine the relationship between mortality and the data (SI, SpO2 and chronic diseases) that can be obtained in ED triage in COVID −19 patients. Statistical analysisIBM SPSS Statistics 25 (Chicago, IL) software was used for statistical analysis. CHAID analysis was used in Decision Tree methods. p < 0.01 was considered statistically significant. Within the scope of the research, the data obtained in the triage and the literature were taken into consideration while determining the variables related to the regression model

No abstract

Objective: To assess and identify the risk of prolonged QT about hydroxychloroquine (HQ) and azithromycin (AZ) used in the treatment of patients with COVID-19.

Our aim in this study is to compare the diagnostic accuracy of chest computed tomography and Real-time Reverse Transcriptase Polymerase Chain Reaction in a population with suspected Coronavirus Disease 2019 (COVID-19) presenting at the emergency department. Material and methods: The study included 257 patients presented to the emergency department with suspected COVID-19. We included all symptomatic patients who received a chest computed tomography and at least one Polymerase Chain Reaction test for detection of COVID-19. The detection rate of COVID-19 infection based on the initial chest computed tomography and Real-time Reverse Transcriptase Polymerase Chain Reaction was compared. Results: A total of 257 patients, 130 women and 127 men, were included in the study. The average age of all patients was 41,12±15,77. Sensitivity of Real-time Reverse Transcriptase Polymerase Chain Reaction test was 71% while that of computed tomography was found to be 49%. The ground glass appearance and/or peripheral distribution findings in 126 patients can be said to be the representative of computed tomography findings for COVID-19. Conclusion: Chest computed tomography should not be used routinely as a screening or diagnostic tool for COVID-19, and additional risks that may arise due to computed tomography imaging should be considered.